Since this summer, the direction of Sanofi, obsessed with firm profitability, considering
hundreds of layoffs. Faced with the inertia of government, employee-es are organized.
Arnaud Montebourg do not hesitate to celebrate the happy surprise: Sanofi, they are "more"
than 900 jobs that management is now planning to remove 2015. The minister is publicly
praised, arguing that "the government's recommendations" were scrupulously observed by
employers. ---- A small bite reminder: last July, the powerful pharmaceutical company
announces proposed "restructuring", which involved the unions deletion of 1 500-2 500
jobs. Line of sight, the sites of Montpellier and Toulouse (industry research), support
functions (services, shopping, etc..) And its subsidiary Sanofi-Pasteur (vaccines).
Immediately, the Minister of Productive Recovery up on his high horse. To achieve, by dint
of successive setbacks, this poor result: nearly a thousand layoffs planned.
In this grim assessment is added threats that management still leaves hang over the
640-employee are the Toulouse site - excluding subcontracting and temporary, which
represent roughly the same number of male and female workers. Because even if Sanofi
eventually erase Toulouse redundancy scheme "official", the company continues to say that
the future of the research center "remains unclear."
Redundancies stock
The pharmaceutical companies have yet through no particular difficulty. Instead, the
benefits are waiting for you, since the group had approximately ? 8.8 billion in profits
in 2011. The purpose of the laboratory suffers no ambiguity minimize investment in
research and increase still further the payment of dividends to shareholders. The company
is also not his first attempt. Between 2009 and 2011, Sanofi has removed about 4,000 jobs
in France, in a favorable situation yet. The rampage social nor has no boundaries. In
2010, plans were similar dismissal for example, was launched in the United States.
Again, the goal of all these "restructuring" - to use a euphemism in use - were based
primarily on considerations stock, whether to upgrade the court actions or provide proof
of return to investors.
Group assisted by the State
At the same time, the pharmaceutical company is overwhelmed with public funding. According
to the local union CGT de Montpellier, it is 130 million euros were generously awarded to
the company for the year 2011 only. Moreover, drug reimbursement by Social Security
benefits also to Sanofi. The exact figures are difficult to evaluate each year, it is at
least several tens of millions of dollars flowing into the coffers and the group. Nothing
too shocking in the eyes of Montebourg, who considers that the laboratory is in the right.
The employee-es, in turn, are determined not to give up. Since the summer of 2012
announcements, actions and events have increased. September 13 held several rallies in
Montpellier, Strasbourg and Toulouse. More than 700 workers were thus gathered in the city
rose to denounce the plans of employers. Sanofi's management obviously means sacrificing
pharmaceutical research and development, accounting for the benefit of reasoning. Social
issues mingle therefore public health problems. Manufacture and distribution of drugs are
too important to be left in the hands of capitalists. Under these conditions, the prospect
of moving to a public organization and self-directed research sites or development
deserves attention. This is also the meaning of the press release of 19 September, signed
by several organizations anticapitalist Toulouse [ 1 ].
Boris - South Paris
[ 1 ] Alternative libertarian, The Alternative, Convergences and alternative Fase, JI ZIP
Bron : a-infos-en@ainfos.ca
Geen opmerkingen:
Een reactie posten